A group of researchers at Harvard Medical School has found that medical industry payments to physicians in Massachusetts are associated with higher rates of prescribing brand-name drugs that treat high cholesterol. The study’s finding, published today in JAMA Internal
Another Study Finds Link Between Pharma Money And Brand-Name Prescribing
The findings, by researchers at Harvard Medical School, are in line with a similar analysis done by ProPublica in March.
